Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROGRESS: Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling

NCT07232355 is registered in ClinicalTrials.gov with Atila Biosystems Inc. as lead sponsor.

NCT NCT07232355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07232355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROGRESS: Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling
Lead sponsor
Atila Biosystems Inc.
Phase
Observational
Overall status
Recruiting
Start date
August 24, 2023
Completion date
June 30, 2026
Enrollment
5,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus